Efficacy of voriconazole on leishmaniasis by Leishmania major: An in vitro and in vivo study

Efficacy of voriconazole on leishmaniasis by Leishmania major: An in vitro and in vivo study

Objective: To appraise the activity of voriconazole against Leishmania major (L. major) in vitro and its effectiveness on wound regeneration in cutaneous leishmaniasis in BALB/c mice. Methods: The IC50 of voriconazole against promastigotes and intra-macrophage amastigotes of L. major was investigate...

Full description

Bibliographic Details
Main Authors:	Ahmad Oryan, Somayeh Bahrami, Effat Bemani
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2018-01-01
Series:	Asian Pacific Journal of Tropical Medicine
Subjects:	leishmania major wound healing azoles voriconazole histopathology
Online Access:	http://www.apjtm.org/article.asp?issn=1995-7645;year=2018;volume=11;issue=10;spage=562;epage=569;aulast=Oryan

Similar Items

Uso de voriconazol en el período neonatal. Reporte de dos casos = Voriconazole use during the neonatal period. Report of two cases
by: Carvajal Kalil, Luis Fernando, et al.
Published: (2011-06-01)

In Vitro and In Vivo Evaluation of Voriconazole-Containing Antifungal Combinations against Mucorales Using a Galleria mellonella Model of Mucormycosis
by: Daiana Macedo, et al.
Published: (2019-01-01)

In Vitro and In Vivo Control of Secondary Bacterial Infection Caused by Leishmania major
by: Hany M. Yehia, et al.
Published: (2017-07-01)

Histological and immunological differences between zoonotic cutaneous leishmaniasis due to Leishmania major and sporadic cutaneous leishmaniasis due to Leishmania infantum
by: Boussoffara Thouraya, et al.
Published: (2019-01-01)

The histopathology of cutaneous leishmaniasis due to Leishmania (Leishmania) mexicana in the Yucatan peninsula, Mexico Histopatologia de la leishmaniasis cutánea causada por Leishmania (Leishmania) mexicana en la península de Yucatán, México
by: Fernando J. Andrade-Narvaez, et al.
Published: (2005-08-01)

An Atypical Presentation of Disseminated Mucocutaneous Leishmaniasis Caused by Leishmania major In Iran
by: Pedram NORMOHAMADPUR, et al.
Published: (2018-03-01)

Healing Effect Comparison of Selenium and Silver Nanoparticles on Skin Leishmanial Lesions in Mice
by: Farnoosh Jameii, et al.
Published: (2015-12-01)

Effect of Echinacea purpurea on Control of Leishmania major Induced Cutaneous Leishmaniasis in Mice
by: MS Sadati, et al.
Published: (2011-04-01)

Detection of Leishmania infantum DNA in the non-parasitized lung of dogs with visceral leishmaniasis
by: Ricardo Goncalves, et al.
Published: (2018-12-01)

Pulmonary delivery of aqueous voriconazole solution
by: Tolman, Justin Andrew
Published: (2012)

Predominance of Leishmania major and rare occurrence of Leishmania tropica with haplotype variability at the center of Iran
by: Amir Hossein Zahirnia, et al.

Method for Therapeutic Drug Monitoring of Voriconazole and its Primary Metabolite Voriconazole-N-oxide in Human Serum using LC-MS/MS
by: Mendy ter Avest, et al.
Published: (2018-10-01)

Super Infection of Cutaneous Leishmaniasis Caused by Leishmania major and L. tropica to Crithidia fasciculata in Shiraz, Iran
by: Aliyar MIRZAPOUR, et al.
Published: (2019-12-01)

Treatment of invasive fungal infections: stability of voriconazole infusion solutions in PVC bags
by: Andréa I.H. Adams, et al.

Imported cutaneous leishmaniasis: molecular investigation unveils Leishmania major in Bangladesh
by: Md Anik Ashfaq Khan, et al.
Published: (2019-11-01)

Recognition of Azole-Resistant Aspergillosis by Physicians Specializing in Infectious Diseases, United States
by: Tiffany A. Walker, et al.
Published: (2018-01-01)

Screening for Azole Resistance among Aspergillus spp isolated from Soil of Hospitals and a University Campus in Gorgan, Iran
by: Zahra Mirshekar, et al.
Published: (2020-07-01)

Further observations on clinical, histopathological, and immunological features of borderline disseminated cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis
by: Fernando T Silveira, et al.
Published: (2005-08-01)

Successful treatment of Chrysosporium keratitis with voriconazole
by: Thanathanee O, et al.
Published: (2017-03-01)

Emergence of Cutaneous Leishmaniasis due to Leishmania major in a New Focus of Southern Iran
by: AA Akhavan, et al.
Published: (2007-06-01)

Leishmania major Cutaneous Leishmaniasis in 3 Travelers Returning from Israel to the Netherlands
by: Justin S. Kuilder, et al.
Published: (2016-11-01)

Interaction between voriconazole and glimepiride
by: Shobha J, et al.
Published: (2010-01-01)

Comparative Gene Expression Profiles of Leishmania major and Leishmania infantum Promastigotes
by: Özlem Ulusan Bağcı, et al.
Published: (2021-06-01)

A case of endogenous trichosporon endophthalmitis treated with micafungin and voriconazole
by: Harpreet Walia, et al.
Published: (2009-01-01)

Geographical Distribution of Leishmania Species of Human Cutaneous Leishmaniasis in Fars Province, Southern Iran
by: M Akhoundi, et al.
Published: (2013-03-01)

Geographical Distribution of Leishmania Species of Human Cutaneous Leishmaniasis in Fars Province, Southern Iran
by: M Akhoundi, et al.
Published: (2013-03-01)

The Impact of Neutrophil Recruitment to the Skin on the Pathology Induced by Leishmania Infection
by: Katiuska Passelli, et al.
Published: (2021-03-01)

Efficacy of Microwave and Infrared Radiation in the Treatment of the Skin Lesions Caused by Leishmania major in an Animal Model
by: SE Eskandari, et al.
Published: (2012-08-01)

Efficacy of Microwave and Infrared Radiation in the Treatment of the Skin Lesions Caused by Leishmania major in an Animal Model
by: SE Eskandari, et al.
Published: (2012-08-01)

Verapamil Inhibits Aspergillus Biofilm, but Antagonizes Voriconazole
by: Hasan Nazik, et al.
Published: (2017-09-01)

Voriconazole-induced periostitis
by: D.C. Fernández Ávila, et al.
Published: (2021-04-01)

In vitro and in vivo activities of Peganum harmala extract against Leishmania major
by: Parvaneh Rahimi-Moghaddam, et al.
Published: (2011-01-01)

Characterization of in Vitro Cultivated Amastigote like of Leishmania major: A Substitution for in Vivo Studies
by: S Kazemian, et al.
Published: (2008-04-01)

Evaluation of Morphine with Imiquimod as Opioid Growth Factor Receptor or Nalmefene as Opioid Blocking Drug on Leishmaniasis Caused by Leishmania major in Vitro
by: Javad JABARI, et al.
Published: (2019-09-01)

Leishmanolysin gp63: Bioinformatics evidences of immunogenic epitopes in Leishmania major for enhanced vaccine design against zoonotic cutaneous leishmaniasis
by: Morteza Shams, et al.
Published: (2021-01-01)

A dhfr-ts- Leishmania major Knockout Mutant Cross-protects against Leishmania amazonensis
by: PST Veras, et al.
Published: (1999-07-01)

Avaliação do papel do receptor marco na infecção de macrófagos murinos por Leishmania major.
by: Almeida, Niara de Jesus
Published: (2014)

Recurrent Acremonium infection in a kidney transplant patient treated with voriconazole: a case report Infecção recidivante por Acremonium em paciente transplantado renal tratado com voriconazol: relato de caso
by: Felipe Francisco Tuon, et al.
Published: (2010-08-01)

Molecular Identification of Leishmania Species Causing Cutaneous Leishmaniasis In Mashhad area, Iran
by: Mohammad Karimian Shirazi, et al.
Published: (2014-08-01)

Anti-leishmanial Activity of Methanolic Extract of Nerium oleander L. against Leishmania major
by: Hamed Noormohammadi, et al.
Published: (2017-11-01)